MU
Micron Technology, Inc.
MU has the edge over PTRN overall, supported by stronger valuation and stronger modeled upside.
PTRN
Pattern Group Inc. Series A Common Stock
PTRN's outlook is improving, though it still trails on the overall score.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
PTRN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Stable | |
| Healthy |
PTRN's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
PTRN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 24x | $18.66 | -11% |
| Fair | 25x | $19.54 | -6.7% |
| Expensive | 27x | $20.44 | -2.5% |
| Current | 27x | $20.95 | — |
| Forward | 28x | $20.95 | — |
Historical ranges are pointers, not guarantees.
PTRN has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over PTRN on the outlook, with more favorable valuation expectations.
PTRN Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for PTRN, with profitability improving.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over PTRN on earnings, with more consistent year-over-year improvement.
PTRN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.76 | -1.3% |
| Q3 2026 | $0.77 | +$2.68 |
| Q2 2026 | -$1.60 | -544% |
| Q1 2026 | -$1.66 | -603% |
| Q4 2025 | -$1.73 | -658% |
| Q3 2025 | -$1.91 | -782% |
PTRN has returned to profit: it earned $0.77 per share over the past year, after losing money the year before.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over PTRN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over PTRN on profitability, with a higher operating margin.
PTRN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $885.8M | +38% |
| Q2 2026 | $876.8M | +47% |
| Q1 2026 | $773.7M | +43% |
| Q4 2025 | $723.1M | +40% |
| Q3 2025 | $639.7M | +46% |
| Q2 2025 | $598.2M | +39% |
| Q1 2025 | $540.4M | +32% |
| Q4 2024 | $515.5M | +31% |
PTRN's revenue has grown year over year every quarter since late 2024: $886M last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.2% | +14 points |
| Q2 2026 | 4% | -1 points |
| Q1 2026 | 5.1% | -0.3 points |
| Q4 2025 | 3.6% | -0.9 points |
| Q3 2025 | -9.4% | -13 points |
| Q2 2025 | 5% | -0.3 points |
| Q1 2025 | 5.4% | -0.2 points |
| Q4 2024 | 4.5% | +0.5 points |
PTRN's operating margin was 4.2% last quarter, up 14 points from the same quarter a year ago.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU generated $59B in free cash flow over the past year, more than ten times what it generated the year before.
PTRN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $3.8M | +$7.1M |
| Q1 2026 | $63.3M | +47% |
| Q2 2025 | -$3.3M | -1297% |
| Q1 2025 | $43.2M | +26% |
PTRN generated $106M in free cash flow over the past year, up 42% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has the edge over PTRN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
PTRN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +1.2M shares |
| 1 year | +79% | +80.7M shares |
PTRN has 182M diluted shares, up 79% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $18.4M |
| Q2 2026 | $94,000 |
| Q1 2026 | $3.6M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q2 2024 | — |
| Q1 2024 | — |
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
PTRN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.2x | Net Cash |
| Q2 2026 | -5.9x | Net Cash |
| Q1 2026 | -6.3x | Net Cash |
| Q4 2025 | -6.5x | Net Cash |
| Q3 2025 | -7.3x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
PTRN has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
PTRN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.7 | Neutral |
| Stochastic | 36.8 | Neutral |
PTRN's weekly RSI is 56 (neutral) and its Stochastic is 37 (neutral).
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.
PTRN PE vs Technology Sector
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
PTRN has stronger trend alignment. MU is above 3 of 5 weekly averages versus PTRN above 3 of 3.
PTRN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.8 | 18% above |
| 20 week MA | $20.8 | 0.7% above |
| 50 week MA | $16.9 | 24% above |
PTRN is in an uptrend: it's above all three of its weekly moving averages, and 24% above its 50-week average.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over PTRN on returns for 2026, with the stronger performance.
PTRN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $15.6 | $11.8 | -24% |
| 2026 YTD | $11.8 | $21.0 | +77% |
PTRN has finished every year since 2025 lower, and it's up 77% so far in 2026.